{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:33:37Z","timestamp":1762144417684},"reference-count":155,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1185\/030079905x75041","type":"journal-article","created":{"date-parts":[[2005,11,12]],"date-time":"2005-11-12T00:29:45Z","timestamp":1131755385000},"page":"1-16","source":"Crossref","is-referenced-by-count":19,"title":["Angiotensin II antagonists \u2013 therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy"],"prefix":"10.1185","volume":"22","author":[{"given":"Artur","family":"Beltrame Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,11,10]]},"reference":[{"key":"CIT0001","first-page":"847","volume":"56","author":"McClellan KJ","year":"1998","journal-title":"A review of its use in essential hypertension. Drugs"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855050-00011"},{"key":"CIT0003","first-page":"1187","volume":"59","author":"Markham A","year":"2000","journal-title":"Jarvis B. Irbesartan: an updated review of its use in cardiovascular disorders. Drugs"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199651050-00008"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262090-00005"},{"key":"CIT0006","first-page":"1501","volume":"61","author":"Sharpe M","year":"2001","journal-title":"Goa KL. Telmisartan: a review of its use in hypertension. Drugs"},{"key":"CIT0007","first-page":"299","volume":"54","author":"Markham A","year":"1997","journal-title":"A review of its pharmacology and therapeutic use in essential hypertension. Drugs"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.1.112"},{"key":"CIT0009","first-page":"861","volume":"9","author":"Dunlay MC","year":"1995","journal-title":"J Hum Hypertens"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00081-Y"},{"key":"CIT0011","first-page":"961","volume":"82","author":"Reif M","year":"1998","journal-title":"Candesartan Cilexetil Study Investigators. Am J Cardiol"},{"issue":"2","key":"CIT0012","first-page":"S69","volume":"11","author":"Sever P","year":"1997","journal-title":"J Hum Hypertens"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1080\/080370599438293"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88300-9"},{"key":"CIT0015","first-page":"129","volume":"17","author":"Hedner T","year":"1999","journal-title":"The Eprosartan Multinational Study Group. J Hypertens"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00053-9"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00784-4"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2003.11.003"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.641"},{"key":"CIT0020","first-page":"111","volume":"9","author":"Lacourciere Y","year":"2002","journal-title":"5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension. Am J Ther"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1080\/080370502320779511"},{"key":"CIT0022","first-page":"861","volume":"12","author":"Benz JR","year":"1998","journal-title":"A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy. J Hum Hypertens"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000615"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04788.x"},{"key":"CIT0025","first-page":"765","volume":"9","author":"Chan JC","year":"1995","journal-title":"J Hum Hypertens"},{"key":"CIT0026","first-page":"1175","volume":"44","author":"Papademetriou V","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118030-00007"},{"key":"CIT0028","first-page":"223","volume":"10","author":"Ruilope L","year":"2001","journal-title":"Prichard B. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial. Blood Press"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1080\/08038020310026781"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83064-7"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427050-00005"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0717-9"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80067-3"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80332-6"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.01481.x"},{"key":"CIT0036","first-page":"795","volume":"18","author":"Farsang C","year":"2000","journal-title":"Losartan ISH Investigators Group. J Hypertens"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80133-9"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/08037050310014954"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01304-2"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200405000-00027"},{"key":"CIT0041","first-page":"327","volume":"101","author":"Samra SS","year":"2003","journal-title":"J Indian Med Assoc"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1742-1241.2003.tb10586.x","volume":"57","author":"Li Y","year":"2003","journal-title":"Int J Clin Pract"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.641"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80101-6"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00054-8"},{"key":"CIT0046","first-page":"310","volume":"6","author":"Papademetriou V","year":"2004","journal-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African\u2013 American patients with hypertension. J Clin Hypertens (Greenwich)"},{"key":"CIT0047","first-page":"392","volume":"2","author":"Association of Black Cardiologists","year":"2000","journal-title":"Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial. Heart Dis"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1185\/03007999909115170"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240111"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)01296-1"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1080\/080370502760050368"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.3.386"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.5.506"},{"key":"CIT0055","first-page":"1021","volume":"35","author":"Jr JL Izzo","year":"2000","journal-title":"Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70312-1"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.3.869"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000917"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001762"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917110-00002"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001781"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-8-200410190-00009"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.11.029"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00446.x"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.12.1491"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08090-X"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1080\/08037050152669684"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001710"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000141573.44737.5A"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1080\/08037050510034185"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.13.1586"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.080"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.14.1653"},{"key":"CIT0079","first-page":"447","volume":"17","author":"Guerra-Cuesta JI","year":"1999","journal-title":"Effect of losartan on human platelet activation. J Hypertens"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00145-4"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464220-00004"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.03.020"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(03)00904-X"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200307006-00007"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2004.019"},{"issue":"2","key":"CIT0086","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/61.suppl_2.S4","volume":"61","author":"Adams KF","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200404060-00002"},{"key":"CIT0088","first-page":"1450","volume":"273","author":"Garg R","year":"1995","journal-title":"Collaborative Group on ACE Inhibitor Trials. JAMA"},{"key":"CIT0089","first-page":"133","volume":"23","author":"Doyle JC","year":"1998","journal-title":"Prescribing of ACE inhibitors for cardiovascular disorders in general practice. J Clin Pharm Ther"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(96)02904-X"},{"key":"CIT0091","first-page":"1056","volume":"100","author":"McKelvie RS","year":"1999","journal-title":"The RESOLVD Pilot Study Investigators. Circulation"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01187-2"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02213-3"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010713"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14284-5"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14283-3"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-9-200411020-00011"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92889-N"},{"key":"CIT0101","first-page":"669","volume":"327","author":"Pfeffer MA","year":"1992","journal-title":"Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med"},{"key":"CIT0102","first-page":"821","volume":"342","author":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","year":"1993","journal-title":"Lancet"},{"key":"CIT0103","first-page":"1115","volume":"343","author":"GISSI-","year":"1994","journal-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico. Lancet"},{"key":"CIT0104","first-page":"80","volume":"332","author":"Ambrosioni E","year":"1995","journal-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200109011-00003"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200109011-00005"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10174"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2002.129251"},{"key":"CIT0109","first-page":"2277","volume":"88","author":"Konstam MA","year":"1993","journal-title":"SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation"},{"key":"CIT0110","first-page":"752","volume":"360","author":"Dickstein K","year":"2002","journal-title":"Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02254-3"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.11.1585"},{"key":"CIT0114","first-page":"253","volume":"355","year":"2000","journal-title":"Heart Outcomes Prevention Evaluation Study Investigators. Lancet"},{"key":"CIT0115","first-page":"703","volume":"317","year":"1998","journal-title":"UK Prospective Diabetes Study Group. BMJ"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.480"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803053381003"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000732"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.7.1182"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00001"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70054-0"},{"key":"CIT0123","first-page":"713","volume":"317","year":"1998","journal-title":"UK Prospective Diabetes Study Group. BMJ"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.37970.629537.0D"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.18"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042274"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.227"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000024416.33113.0A"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.07715.x"},{"issue":"1","key":"CIT0133","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/ajhp\/57.suppl_1.S12","volume":"57","author":"Manley HJ","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"CIT0134","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1681\/ASN.V4140","volume":"4","author":"Remuzzi A","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_1.90"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00224.x"},{"key":"CIT0137","first-page":"S120","volume":"68","author":"Fernandez-Andrade C","year":"1998","journal-title":"Comparison of losartan and amlodipine in renally impaired hypertensive patients. Kidney Int Suppl"},{"key":"CIT0138","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.06827.x"},{"key":"CIT0139","first-page":"S37","volume":"12","author":"Gansevoort RT","year":"1994","journal-title":"J Hypertens Suppl"},{"key":"CIT0140","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.12.3096"},{"key":"CIT0141","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00385.2002"},{"key":"CIT0142","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.V9101948","volume":"9","author":"Amuchastegui SC","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.113"},{"key":"CIT0144","doi-asserted-by":"publisher","DOI":"10.1159\/000078950"},{"key":"CIT0145","first-page":"169","volume":"57","author":"Cupisti A","year":"2003","journal-title":"Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients. Biomed Pharmacother"},{"key":"CIT0146","first-page":"1291","volume":"11","author":"Luno J","year":"2005","journal-title":"The reno-protective effect of the dual blockade of the renin angiotensin system (RAS). Curr Pharm Des"},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12229-5"},{"key":"CIT0148","first-page":"847","volume":"21","author":"Mimran A","year":"1999","journal-title":"Angiotensin II receptor antagonists and hypertension. Clin Exp Hypertens"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921010-00003"},{"key":"CIT0150","first-page":"82","volume":"2","author":"Mallion JM","year":"1996","journal-title":"Blood Press Suppl"},{"key":"CIT0151","first-page":"885","volume":"54","author":"Gillis JC","year":"1997","journal-title":"A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1080\/080370502760050412"},{"key":"CIT0154","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200311000-00005"},{"key":"CIT0155","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.130.12.1416"},{"key":"CIT0156","first-page":"375","volume":"4","author":"Sica DA","year":"2002","journal-title":"Greenwich"},{"key":"CIT0157","first-page":"41","volume":"160","author":"Caro JJ","year":"1999","journal-title":"CMAJ"},{"key":"CIT0158","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80130-6"},{"key":"CIT0161","doi-asserted-by":"publisher","DOI":"10.1254\/fpj.124.257"},{"key":"CIT0162","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2005.002"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079905X75041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:47:14Z","timestamp":1683283634000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079905X75041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,10]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,11,10]]},"published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1185\/030079905X75041"],"URL":"https:\/\/doi.org\/10.1185\/030079905x75041","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,10]]}}}